A five-fraction, one-week schedule of adjuvant breast radiotherapy is as safe and effective as a standard three-week schedule ...

More information: PORTEC-4a; an international randomised trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer, Radiotherapy and Oncology (2025).

Depending on tumor location, presurgical radiation can improve overall survival, but that option comes with an increased risk ...

Agustí and colleagues conducted a cohort study to evaluate whether adjuvant chemoradiotherapy improved OS compared with radiotherapy alone in this patient population. They used prospectively ...

Discover a study that evaluated the effectiveness of hyperbaric oxygen therapy for radiation-induced dermatitis.

In certain disease sites (eg, lymphoma and early-stage endometrial cancer), adjuvant radiation therapy is found to benefit event-free survival but not necessarily overall survival. In this ...

Study authors examined the diagnostic utility of radiologic imaging for patients with high-risk cutaneous squamous cell carcinoma.

Although, some studies with adjuvant and neoadjuvant radiotherapy showed improved local control and overall survival benefits in the 1970s and 1980s, they failed in other areas. Limitations of old ...

The international PORTEC-4a study offers strong evidence that molecular profiling can safely minimize radiotherapy in women ...

For women with high-intermediate risk disease, adjuvant radiotherapy — particularly vaginal brachytherapy (a form of internal radiotherapy delivered directly to the vaginal area) — is commonly ...

50 After the completion of adjuvant chemotherapy as well as adjuvant radiotherapy, long-term monitoring of disease status and survival is planned as check-ups once every 3 months for the first 2 years ...